✦ LIBER ✦

Addition of chlorthalidone to slow-release nifedipine in the treatment of arterial hypertension: A controlled study versus placebo

✍ Scribed by Liberato Aldo Ferrara; Teodoro Marotta; Fabrizio Pasanisi; Paolo Mastranzo; Mario Mancini

Publisher: Springer US
Year: 1988
Tongue: English
Weight: 370 KB
Volume: 1
Category: Article
ISSN: 0920-3206
DOI: 10.1007/bf02125751

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nifedipine versus carvedilol in the trea

Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: Results of a controlled clinical trial

✍ Alessandra Galioto; Andrea Semplicini; Giacomo Zanus; Silvano Fasolato; Antoniet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

The aim of this study was to compare nifedipine and carvedilol in the treatment of de novo arterial hypertension after orthotopic liver transplantation (OLT). The study included 50 patients who developed arterial hypertension after OLT. Twenty-five patients received nifedipine (group A), and 25 rece

Twenty-four-hour blood pressure monitori

Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study

✍ D. Bonaduce; V. Canonico; M. Petretta; L. Forgione; A. Ianniciello; V. Cavallaro 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 149 KB

A double-blind comparison of once-daily

A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension

✍ Ming-Fong Chen; Chi-Yu Yang; Wen-Jone Chen; Chii-Ming Lee; Chau-Chung Wu; Chiau- 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 537 KB

Double-blind, placebo-controlled study t

Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

✍ Francesca Mancini; Roberta Zangaglia; Silvano Cristina; Maria Grazia Sommaruga; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract Drooling is a frequent symptom in Parkinson's disease (PD), occurring in almost 75% of all patients. Although it is now well known that drooling in PD is the result of swallowing difficulties rather than excessive saliva production, few treatments have been developed to reduce it. Clini

A placebo-controlled study of sertraline

A placebo-controlled study of sertraline’s effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adults

✍ Linda L. Carpenter; Audrey R. Tyrka; Janet K. Lee; Aaron P. Tracy; Charles W. Wi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 187 KB

Efficacy of selegiline add on therapy to

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of